The Valley Desk

NCT03586024 · Interventional trial

Pembrolizumab in Relapsed or Refractory Extranodal NK/T- Cell Lymphoma, Nasal Type and EBV-associated Diffuse Large B Cell Lymphomas

Overall registry status Withdrawn

Phase 1 · Phase 2

Conditions Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov